Discngine Labs: Predicting Antibody Developability – In sil...

Discngine Labs: Predicting Antibody Developability – In silico & In vitro synergies

Therapeutic antibodies have become one of the fastest-growing drug classes in clinics. However, despite major advances in discovery processes and technologies, their successful development is often hindered by developability challenges in design and production. Therefore, methods that predict and prevent the possibility of antibody candidate failure at a later stage of development are very beneficial.

The fifth Discngine Labs will provide insights on how to successfully develop therapeutic antibodies using a combination of in silico and in vitro approaches. In the roundtable, the experts from pharma R&D will discuss their strategies for combining these two methodologies, which lead them to improved predictions and increased efficiency in antibody development.

The event will cover:

• Antibody interaction predictions
• De Novo design
• In-vitro methods

To know more: https://bit.ly/3Yisabm

• Discover all events